Royalty Pharma Class A Shs's chart data is dated 2026-10-09. There is no active technical signal. There are 13 published signal records.
Royalty Pharma Class A Shs last closed at $56.93 (+1.28%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is 38.4×. Its overall grade ranks 382 of 738 stocks in Healthcare.
About this company
Royalty Pharma Class A Shs last closed at $56.93 (+1.28%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B- · 382/738
Valuation grade F
Dividends
2025 dividend per share · $0.8800 · Yield 1.61%
Details →Related stocks
- RocheCustomer
로열티 대상 의약품의 상업화 파트너로 큰 매출원이 될 수 있음
- BiogenCustomer
주요 로열티 자산인 신경과 의약품 매출과 직접 연결
- AstraZenecaCustomer
다수의 로열티 계약 및 상업화 약물 매출과 연계
ETFs holding this stock
Invesco Dynamic BioTech & Genome ETF · iShares US Pharmaceuticals ETF · ALPS O'Shares US Small-Cap Quality Dividend ETF
Details →About Royalty Pharma Class A Shs
- What technical signals does Royalty Pharma Class A Shs (RPRX) have?
- Royalty Pharma Class A Shs current technical signals: no active technical signal.
- Is Royalty Pharma Class A Shs a cup-and-handle pattern?
- No. Royalty Pharma Class A Shs has no valid Cup signal right now.
- What published figures are available for Royalty Pharma Class A Shs?
- Market cap: $33.32B. Trailing 12 months PER: 38.4×. Latest quarter PBR: 3.20×. Dividend yield: 1.61%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Royalty Pharma Class A Shs, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.